Contact this trialFirst, we need to learn more about you.
Fluorine F 18 Ara-G for Non-Small Cell Lung Cancer
Recruiting1 awardPhase < 1
Sacramento, California
This trial is studying how well a radiotracer called [18F]-AraG works in detecting T-cell activation in patients with advanced non-small cell lung cancer who are undergoing PD-1/PD-L1-directed therapy. [18F]-AraG may improve the ability to detect a response of the cancer in the body to immunotherapy.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service